<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04750551</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-20-1286 (Experiment 1)</org_study_id>
    <nct_id>NCT04750551</nct_id>
  </id_info>
  <brief_title>BreEStim for Motor Recovery in Chronic Stroke With Moderate Impairment (Pilot).</brief_title>
  <official_title>BreEStim for Post-Stroke Motor Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall goal is to investigate the effectiveness of a novel intervention -&#xD;
      Breathing-controlled electrical stimulation (BreEStim) on finger flexor spasticity reduction&#xD;
      and hand function improvement in chronic stroke with moderate impairment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2, 2021</start_date>
  <completion_date type="Anticipated">August 10, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 10, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in finger flexor spasticity measured by Modified Ashworth Scale (MAS)</measure>
    <time_frame>Baseline, 5 minutes after intervention</time_frame>
    <description>MAS will be performed to check changes of finger flexor spasticity after one session of treatment.&#xD;
The Modified Ashworth scale (MAS) scoring is categorical and ranges from 0 to 4, as follows:&#xD;
0: No increase in muscle tone&#xD;
Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension 1+: Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the range of motion (ROM)&#xD;
More marked increase in muscle tone through most of the ROM, but affected part(s) easily moved&#xD;
Considerable increase in muscle tone, passive movement difficult&#xD;
Affected part(s) rigid in flexion or extension</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in finger extensors and hand function measured by Fugl Myer Assessment (FMA) Scale</measure>
    <time_frame>Baseline, 5 minutes after intervention</time_frame>
    <description>FMA will be assessed to test function changes of finger extensors and hand function after one session of treatment.&#xD;
The upper limb motor function domain of the FMA scale will be used, and the score range for this domain is 0 to 66, with a higher score indicating better function.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">4</enrollment>
  <condition>Motor Recovery</condition>
  <arm_group>
    <arm_group_label>BreEStim</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BreEStim is voluntary breathing controlled transcutaneous electrical nerve stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EStim</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EStim is transcutaneous electrical nerve stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BreEStim</intervention_name>
    <description>BreEStim will applied for 10 to 20 minutes.</description>
    <arm_group_label>BreEStim</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EStim</intervention_name>
    <description>EStim will applied for 10 to 20 minutes.</description>
    <arm_group_label>EStim</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  has post stroke ≥ 6 months , medically stable;&#xD;
&#xD;
          -  Unilateral, single stroke (no restriction on type (ischemic or hemorrhagic) or volume&#xD;
             (large or small) of stroke);&#xD;
&#xD;
          -  MAS score ≥ 1, i.e., detectable finger flexor hypertonia;&#xD;
&#xD;
        Exclusion criteria include:&#xD;
&#xD;
          -  Patients with visual deficit/neglect; hearing or cognitive impairment;&#xD;
&#xD;
          -  Patients with history of pulmonary disease (Asthma, chronic obstruction pulmonary&#xD;
             disease, COPD);&#xD;
&#xD;
          -  Patients that are currently adjusting tone alternating medications (e.g., baclofen),&#xD;
             or&#xD;
&#xD;
          -  Patients received botulinum toxin injection to the arm/fingers &lt;4 months, or phenol&#xD;
             injections &lt; 2 years;&#xD;
&#xD;
          -  Patients with a pacemaker;&#xD;
&#xD;
          -  Women who are pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sheng Li, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sheng Li, MD, PhD</last_name>
    <phone>(713) 797-7125</phone>
    <email>sheng.li@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shengai Li, MS</last_name>
    <phone>713-797-7561</phone>
    <email>shengai.li@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Texas Health Science Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheng Li, MD, PhD</last_name>
      <phone>713-500-5874</phone>
      <email>sheng.li@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Shengai Li, MS</last_name>
      <phone>713-797-7561</phone>
      <email>shengai.li@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 10, 2021</study_first_submitted>
  <study_first_submitted_qc>February 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>May 21, 2021</last_update_submitted>
  <last_update_submitted_qc>May 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Sheng Li</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Finger flexor spasticity</keyword>
  <keyword>Motor Recovery</keyword>
  <keyword>BreEStim</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

